Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas (RADIOCYST01)

NCT02343692 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT02343692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02343692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas (RADIOCYST01)
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2016
Completion date
August 31, 2020
Enrollment
97 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cyst